Phathom Pharmaceuticals logo

Phathom Pharmaceuticals share price today

(PHAT)

Phathom Pharmaceuticals share price is $7.5 & ₹638.98 as on 25 Dec 2024, 2.30 'hrs' IST

$7.5

-0.11

(-1.45%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Phathom Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Phathom Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Phathom Pharmaceuticals. Get details on the Indian mutual funds that are investing in Phathom Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Phathom Pharmaceuticals's financials.

Phathom Pharmaceuticals share price movements

  • Today's Low: $7.24
    Today's High: $7.59

    Day's Volatility :4.68%

  • 52 Weeks Low: $6.07
    52 Weeks High: $19.71

    52 Weeks Volatility :69.23%

Phathom Pharmaceuticals Returns

PeriodPhathom Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-57.91%
-9.0%
0.0%
6 Months
-27.88%
-4.6%
0.0%
1 Year
-19.01%
3.0%
0.0%
3 Years
-62.5%
0.0%
-21.1%

Phathom Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$7.61
Open
$7.59
Today's High
$7.59
Today's Low
$7.235
Market Capitalization
$512.8M
Today's Volume
$401.5K
52 Week High
$19.71
52 Week Low
$6.065
Revenue TTM
$26.3M
EBITDA
$-287.1M
Earnings Per Share (EPS)
$-5.74
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3489.0%

How to invest in Phathom Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Phathom Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Phathom Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Phathom Pharmaceuticals or PHAT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Phathom Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Phathom Pharmaceuticals shares which would translate to 0.114 fractional shares of Phathom Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Phathom Pharmaceuticals, in just a few clicks!

Returns in Phathom Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Phathom Pharmaceuticals investment value today

Current value as on today

₹83,232

Returns

₹16,768

(-16.77%)

Returns from Phathom Pharmaceuticals Stock

₹19,006 (-19.01%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Phathom Pharmaceuticals

71%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Phathom Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 71% more investors are searching Phathom Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Phathom Pharmaceuticals

  • Medicxi Ventures Management (Jersey) Ltd

    10.92%

  • Jennison Associates LLC

    8.58%

  • Amvescap Plc.

    5.99%

  • The Carlyle Group Inc

    5.11%

  • BlackRock Inc

    4.28%

  • Vanguard Group Inc

    3.94%

Analyst Recommendation on Phathom Pharmaceuticals

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Phathom Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Phathom Pharmaceuticals

What analysts predicted

Upside of 231.43%

Current:

$7.50

Target:

$24.86

Insights on Phathom Pharmaceuticals

  • Price Movement

    In the last 7 days, PHAT stock has moved down by -4.1%
  • PHAT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 45.7%
  • PHAT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 87.3%
  • Price to Sales

    ForPHAT every $1 of sales, investors are willing to pay $17.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Phathom Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Phathom Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Phathom Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Phathom Pharmaceuticals Inc
-16.39%
-27.88%
-19.01%
-62.5%
-76.92%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Phathom Pharmaceuticals Inc
NA
NA
NA
-4.69
-34.89
-0.58
NA
-2.74
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Phathom Pharmaceuticals Inc
Buy
$512.8M
-76.92%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Phathom Pharmaceuticals

phathom pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. the company has the rights in the united states, europe, and canada to vonoprazan, a potassium-competitive acid blocker (p-cab) that blocks acid secretion in the stomach. it is also developing vonoprazan, which is in phase iii clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of helicobacter pylori infection. the company was incorporated in 2018 and is based in buffalo grove, illinois.
Organization
Phathom Pharmaceuticals
Employees
452
CEO
Ms. Terrie J. Curran
Industry
Health Technology

Management People of Phathom Pharmaceuticals

NameTitle
Ms. Terrie J. Curran
President, CEO & Director
Mr. David A. Socks
Co-Founder & Director
Dr. Azmi Nabulsi M.D., M.P.H.
Co-Founder & COO
Ms. Molly Henderson CPA, MBA
Chief Financial & Business Officer
Dr. Aditya Kohli Ph.D.
Co-Founder
Mr. Paul Cocja
Chief People Officer
Mr. Tom Harris
Chief Development Sciences Officer
Dr. Eckhard Leifke M.D., Ph.D.
Chief Medical Officer
Mr. Martin J. Gilligan
Chief Commercial Officer

Important FAQs about investing in Phathom Pharmaceuticals from India :

What is Phathom Pharmaceuticals share price today?

Phathom Pharmaceuticals share price today stands at $7.50, Open: $7.59 ; Previous Close: $7.61 ; High: $7.59 ; Low: $7.24 ; 52 Week High: $19.71 ; 52 Week Low: $6.07. The stock opens at $7.59, after a previous close of $7.61. The stock reached a daily high of $7.59 and a low of $7.24, with a 52-week high of $19.71 and a 52-week low of $6.07.

Can Indians buy Phathom Pharmaceuticals shares?

Yes, Indians can invest in the Phathom Pharmaceuticals (PHAT) from India.

With INDmoney, you can buy Phathom Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Phathom Pharmaceuticals at zero transaction cost.

How can I buy Phathom Pharmaceuticals shares from India?

It is very easy to buy Phathom Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Phathom Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Phathom Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Phathom Pharmaceuticals stocks?

To start investing in Phathom Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Phathom Pharmaceuticals

Today’s highest price of Phathom Pharmaceuticals (PHAT) is $7.59.

Today’s lowest price of Phathom Pharmaceuticals (PHAT) is $7.24.

What is today's market capitalisation of Phathom Pharmaceuticals

Today's market capitalisation of Phathom Pharmaceuticals PHAT is 512.8M

What is the 52 Week High and Low Range of Phathom Pharmaceuticals

  • 52 Week High

    $19.71

  • 52 Week Low

    $6.07

What are the historical returns of Phathom Pharmaceuticals?

  • 1 Month Returns

    -16.39%

  • 3 Months Returns

    -27.88%

  • 1 Year Returns

    -19.01%

  • 5 Years Returns

    -76.92%

Who is the Chief Executive Officer (CEO) of Phathom Pharmaceuticals

Ms. Terrie J. Curran is the current Chief Executive Officer (CEO) of Phathom Pharmaceuticals.